Transpek Industry Intrinsic Value
Transpek Industry (TRANSPEK) median intrinsic value is ₹880.00 from 8 valuation models (range ₹321–₹2674), vs current price ₹1069.60 — -17.7% downside (Trading Above Median Value), margin of safety -21.5%. Also explore Transpek Industry share price performance to track price trends across different timeframes.
TRANSPEK Valuation Methods Summary — DCF, Graham Number & P/E
Transpek Industry intrinsic value across 8 models vs current price ₹1069.60 — upside/downside and value range per method. Browse TRANSPEK complete financial statements for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹565.44 | ₹452.35 - ₹678.53 | -47.1% | EPS: ₹47.12, Sector P/E: 12x |
| Book Value Method | asset | ₹1241.67 | ₹1117.50 - ₹1365.84 | +16.1% | Book Value/Share: ₹1241.67, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹816.00 | ₹734.40 - ₹897.60 | -23.7% | Revenue/Share: ₹1020.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹880.00 | ₹792.00 - ₹968.00 | -17.7% | EBITDA: ₹88.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹2674.00 | ₹2139.20 - ₹3208.80 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹320.88 | ₹288.79 - ₹352.97 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹388.27 | ₹349.44 - ₹427.10 | -63.7% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹1147.35 | ₹1032.62 - ₹1262.09 | +7.3% | EPS: ₹47.12, BVPS: ₹1241.67 |
TRANSPEK Intrinsic Value vs Market Price — All Valuation Models
Transpek Industry fair value range ₹321–₹2674 vs current market price ₹1069.60 across 8 valuation models. For current market price and key ratios, visit TRANSPEK screener.
TRANSPEK Intrinsic Value Analysis — Undervalued or Overvalued?
Transpek Industry median intrinsic value ₹880.00, current price ₹1069.60 — Trading Above Median Value by 17.7%, margin of safety -21.5%.
What is the intrinsic value of TRANSPEK?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Transpek Industry (TRANSPEK) is ₹880.00 (median value). With the current market price of ₹1069.60, this represents a -17.7% variance from our estimated fair value.
The valuation range spans from ₹320.88 to ₹2674.00, indicating ₹320.88 - ₹2674.00.
Is TRANSPEK undervalued or overvalued?
Based on our multi-method analysis, Transpek Industry (TRANSPEK) appears to be trading above median value by approximately 17.7%.
TRANSPEK Financial Health — Key Ratios vs Industry Benchmarks
Transpek Industry financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.25 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 12.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.61x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
TRANSPEK Cash Flow Quality — Operating & Free Cash Flow
Transpek Industry operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹135 Cr | ₹120 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹98 Cr | ₹82 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹111 Cr | ₹105 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹47 Cr | ₹12 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹35 Cr | ₹27 Cr | Positive Free Cash Flow | 8/10 |